NIH Diabetes Discoveries & Practice Blog - October 28, 2020
Earle Chambers, Ph.D., M.P.H., discusses social and economic conditions—such as barriers to accessing healthy food, stable housing, and safe recreational areas—and how these factors affect patients' ability to manage their risk of developing diabetes. Dr. Chambers is director of the division of research in the department of family and social medicine and associate professor of family and social medicine and of epidemiology & population health at Einstein and Montefiore.
Dr. Chambers' ProfileMore coverage on Dr. Chambers
CNN - October 15, 2020
Joe Verghese, M.B.B.S., M.S., comments on a study that found apathy in older adults could be a risk factor for dementia and notes his prior research suggests that addressing apathy could help delay the onset of dementia. Dr. Verghese is chief of geriatrics at Einstein and Montefiore and director of the Montefiore Einstein Center for the Aging Brain.
Dr. Verghese's ProfileMore coverage on Dr. Verghese
The New York Times - October 12, 2020
Kartik Chandran, Ph.D., describes the efforts of a multi-institutional collaboration he is leading to discover a potent, long-lasting antibody that would be effective against a range of coronaviruses, not only the one that causes COVID-19. Dr. Chandran is professor of microbiology & immunology and the Harold and Muriel Block Scholar in Virology at Einstein.
Dr. Chandran's ProfileMore coverage on Dr. Chandran
The New York Times - September 25, 2020
Betsy Herold, M.D., describes her new research that may help explain why the novel coronavirus affects children less severely than adults. Dr. Herold is chief of pediatric infectious diseases and vice chair for pediatrics research at Einstein and Montefiore and the Harold and Muriel Block Chair in Pediatrics.
Additional Coverage includes Science News, The Scientist, Associated Press, Yahoo, WebMD, The Telegraph (subscription required), Health Day, Marketwatch, Axios, Becker's Hospital Review
Dr. Herold's ProfileMore coverage on Dr. Herold
Science - September 17, 2020
Matthew Akiyama, M.D., says accelerated decarceration due to the COVID-19 pandemic may have led to less rigorous discharge planning for people in jails and prisons who already have difficulty accessing medical care, treatment for addiction, and other services to help them re-enter society. Dr. Akiyama is assistant professor of medicine at Einstein and an internist at Montefiore.
Dr. Akiyama's ProfilMore coverage on Dr. Akiyama's Profil
Refinery29 - September 9, 2020
Michael Lipton, M.D., Ph.D., discusses his study on the association between oral contraception use and the size of the brain’s hypothalamus in women. Dr. Lipton is professor of radiology and associate director of the Gruss Magnetic Resonance Research Center at Einstein, and director of MRI Services at Montefiore.
Dr. Lipton's ProfileMore coverage on Dr. Lipton
The New Yorker - September 8, 2020
Liise-anne Pirofski, M.D., discusses the use of plasma from people who have recovered from COVID-19 to potentially prevent and treat the disease. Dr. Pirofski is chief of infectious diseases at Einstein and Montefiore.
Additional Coverage includes Los Angeles Times, The Lancet, CNN, USA Today, Nature, The Atlantic, Wall Street Journal (subscription required ), Associated Press, NPR, LA Times, NBC News, CBS News
More CoverageDr. Pirofski's ProfileMore coverage on Dr. Pirofski
NIH Diabetes Discoveries & Practice Blog - August 26, 2020
Martin Grajower, M.D., offers tips to people with diabetes to help them avoid health problems while fasting. Dr. Grajower is clinical professor of medicine at Einstein and an endocrinologist and internal medicine physician at Montefiore.
Dr. Grajower's Profile
National Geographic - August 24, 2020
Liise-anne Pirofski, M.D. comments on the FDA's decision to issue an emergency use authorization for convalescent plasma to treat patients with COVID-19, and stresses the need for randomized clinical trials to provide answers on its efficacy. Dr. Pirofski is chief of infectious diseases at Einstein and Montefiore.
Additional Coverage includes Science News, NPR (relevant interview starts at 1:40), U.S. News & World Report (via HealthDay), The Wall Street Journal, Politico, Medscape, MedPage Today, WIRED
Dr. PirofskiMore coverage on Dr. Pirofski